***Background.*** Neutropenia is a known adverse effect of the cephalosporin antibiotic class, however it has not been well described with ceftaroline -- a 5^th^ generation cephalosporin with activity against methicillin-resistant *Staphylococcus aureus* (MRSA). We describe two cases in which patients experienced neutropenia while receiving ceftaroline for MRSA infections.

***Methods.*** The first patient was a 33 year-old male with a history of intravenous drug use who developed MRSA tricuspid and mitral valve endocarditis with a vancomycin MIC of 2 mcg/mL and daptomycin MIC of 1 mcg/mL. After blood cultures remained positive with vancomycin, antibiotics were changed to ceftaroline 600 mg every 8 hours and daptomycin 8 mg/kg daily. After 32 days of therapy, the ANC decreased to 140/µL and ceftaroline and daptomycin were discontinued. With filgrastim, his ANC recovered after 7 days.

The second patient was a 37 year-old female admitted for severe gastroparesis and diabetes, found to have MRSA bacteremia with a vancomycin MIC of 2 mcg/mL. She was treated with vancomycin and then switched to daptomycin as blood cultures remained positive for 14 days. She was found to have a renal abscess and pyelonephritis but no other metastatic foci and was discharged on daptomycin. She was readmitted with CPK elevation \> 1,000 mg/dL and peripheral eosinophilia thought to be due to daptomycin and was switched to ceftaroline 600 mg every 12 hours. After 20 days of inpatient and outpatient treatment, she was re-admitted with back pain and found to have an MRI consistent with septic arthritis of L3-L4 at which time vancomycin was added and ceftaroline increased to 600 mg every 8 hours. After 15 days of combination therapy, her ANC decreased to 1,000/µL (WBC of 2,900/µL). Ceftaroline was discontinued and 7 days later, her ANC and WBC normalized. She continued vancomycin monotherapy.

***Results.*** Using the Naranjo scale, the likelihood of ceftaroline causing neutropenia in case 1 was possible (score of 4) and in case 2 was probable (score of 7).

***Conclusion.*** In both of these patients, long courses of high dose ceftaroline were used to treat complicated MRSA infections. Patients should be closely monitored for neutropenia while receiving ceftaroline, particularly those receiving treatment with every 8 hour dosing for longer than 14 days.
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